Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer
详细信息 查看全文
- 作者：Gui-fang Xu ; Wei-jie Zhang ; Qi Sun ; Xinyun Xu…
- 刊名：World Journal of Surgical Oncology
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：12
- 期：1
- 全文大小：333 KB
- 参考文献：1. Steinestel, K, Eder, S, Schrader, AJ, Steinestel, J (2014) Clinical significance of epithelial-mesenchymal transition. Clin Transl Med 3: pp. 17 CrossRef
2. Takaishi, S, Okumura, T, Tu, S, Wang, SS, Shibata, W, Vigneshwaran, R, Gordon, SA, Shimada, Y, Wang, TC (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: pp. 1006-1020 CrossRef
3. Chen, T, Yang, K, Yu, J, Meng, W, Yuan, D, Bi, F, Meng, W, Yuan, D, Bi, F, Liu, F, Liu, J, Dai, B, Chen, X, Wang, F, Zeng, F, Xu, H, Hu, J, Mo, X (2012) Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 22: pp. 248-258 CrossRef
4. Stojnev, S, Krstic, M, Ristic-Petrovic, A, Stefanovic, V, Hattori, T (2014) Gastric cancer stem cells: therapeutic targets. Gastric Cancer 17: pp. 13-25 CrossRef
5. Ryu, HS, Park Do, J, Kim, HH, Kim, WH, Lee, HS (2012) Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 43: pp. 520-528 CrossRef
Edge, SB, Byrd, DR, Carolyn, CC, Fritz, AG, Greene, FL, Trotti, A eds. (2010) AJCC Cancer Staging Manual. Springer, Chicago, IL
6. Hsu, FD, Nielsen, TO, Alkushi, A, Dupuis, B, Huntsman, D, Liu, CL, van de Rijn, M, Gilks, CB (2002) Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15: pp. 1374-1380 CrossRef
7. Li, F, Zhang, R, Liang, H, Liu, H, Quan, J (2013) The pattern and risk factors of recurrence of proximal gastric cancer after curative resection. J Surg Oncol 107: pp. 130-135 CrossRef
8. Otsuji, E, Kuriu, Y, Ichikawa, D, Okamoto, K, Ochiai, T, Hagiwara, A, Yamagishi, H (2004) Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg 28: pp. 866-869 CrossRef
9. Eom, BW, Yoon, H, Ryu, KW, Lee, JH, Cho, SJ, Lee, JY, Kim, CG, Choi, IJ, Lee, JS, Kook, MC, Park, SR, Nam, BH, Kim, YW (2010) Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg 27: pp. 481-486 CrossRef
10. Fan, QM, Jing, YY, Yu, GF, Kou, XR, Ye, F, Gao, L, Li, R, Zhao, QD, Yang, Y, Lu, ZH, Wei, LX (2014) Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 352: pp. 160-168 CrossRef
11. Wellner, U, Schubert, J, Burk, UC, Schmalhofer, O, Zhu, F, Sonntag, A, Waldvogel, B, Vannier, C, Darling, D, zur Hausen, A, Brunton, VG, Morton, J, Sansom, O, Schüler, J, Stemmler, MP, Herzberger, C, Hopt, U, Keck, T, Brabletz, S, Brabletz, T (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting micro-RNAs. Nat Cell Biol 11: pp. 1487-1195 CrossRef
12. Chen, S, Hou, JH, Feng, XY, Zhang, XS, Zhou, ZW, Yun, JP, Chen, YB, Cai, MY (2013) Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. J Surg Oncol 107: pp. 799-806 CrossRef
13. Wakamatsu, Y, Sakamoto, N, Oo, HZ, Naito, Y, Uraoka, N, Anami, K, Sentani, K, Oue, N, Yasui, W (2012) Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62: pp. 112-119
文摘
Background The aim of the study was to identify the incidence and the predictors of recurrence after curative resection and the clinical significance of epithelial-mesenchymal transition (EMT) and stem cell-like phenotypes in gastric cancer. Methods In a total of 1,463 patients that underwent curative resection for gastric cancer between January 2001 and January 2008 at Drum Tower Hospital, 402 (27.5%) experienced recurrence. They were divided into early recurrence (within two years) and late recurrence (more than two years). The clinicopathological characteristics, including five EMT-related proteins (Snail-1, ZEB-1, E-cadherin, vimentin, and β-catenin) and the gastric cancer stem cell markers CD44 and CD54, therapeutic modalities, survival time after recurrence, and recurrence patterns were compared between the two groups. Results Loss of E-cadherin expression and aberrant expression of vimentin and the known gastric cancer stem cell maker CD44 were significantly associated with aggressive clinicopathologic features. Multivariate analysis showed that stage III gastric cancer patients with early recurrence had larger tumors and more lymph node metastasis, coupled with aberrant expression EMT and cancer stem cell marker, than patients with late recurrence. Early recurrence was associated with more distant metastasis than late recurrence and patients tended to die within two years of recurrence. Conclusions Combined EMT with cancer stem cell-like marker is a predictor of recurrence after radical resection for gastric cancer. Advanced TNM stage was associated with early cancer death after recurrence.